Cardiovascular Diabetology | Abstract | Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins

Links shared publicly online about this topic.

159
total visits

Cardiovascular Diabetology | Abstract | Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins

Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications effectively reduce fasting LDL cholesterol and triglycerides concentrations and several of them routinely reduce CVD risk. However, in contemporary Western societies the vasculature is commonly exposed to prolonged postprandial hyperlipidemia. Metab

View full resource at cardiab.com

Tags: Heart, Heart Disease, Diabetes, Type 2 Diabetes, Disease and Condition, Drug, disease